- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04649047
Lifestyle Behavior Weight Loss Intervention
Weight Loss Intervention for Mothers With Young Children
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Body mass index of 25.0-39.9 kg/m2 (calculated using height and weight)
- Current enrollment in government assistant programs (for example, WIC, food stamp (SNAP), or Madicaid)
- 6 weeks - 3.5 years postpartum
- 18-45 years old
- Fluency in speaking, reading, and writing English
- Ownership of a smart phone with unlimited text messages and internet access
- Committed to a three-week intervention study
Exclusion Criteria:
- Current pregnancy or lactation
- Plan to become pregnant during the trial
- Type 1 or 2 diabetes
- Untreated thyroid disease
- Drug or alcohol abuse or dependence within last six months
- Major psychiatric disorder (e.g., schizophrenia, bipolar)
- History of bulimia or anorexia
- Current taking of appetite suppressant or (antipsychotic) medications known to affect body weight
- Current participation in a weight control or drug study
- Current or planned participation in a commercial weight loss program
- Previous weight loss surgery
- Contraindications to physical activity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
All participants will be assigned to the experimental group and receive a 3-weekly intervention via web and individual health coaching.
The educational topics cover stress management, healthy eating, and physical activity
|
All participants will receive a 3-week web-based intervention plus individual health coaching.
The intervention topics include stress management, healthy eating, and physical activity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Body Weight
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
Self-reported body weight
|
baseline (T1) and 3 weeks follow up (T2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Mass Index
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
kg/m^2
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Daily Dietary Fat Intake
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
NCI brief dietary fat intake survey was used to measure dietary fat intake. Participants reported the frequency of each specific food eaten over the past 12 months. Values are:1 = never, 2 = less than once per month,3 = 1-3 times per week, 4 = 3-4 times per week,5 = 5-6 times per week, 6 = 1 time per day, 7 = 2 or more times per day. Higher scores indicate more frequent fat intake.There is no minimum or maximum available for this measure. The following procedures were used to convert an individual's responses to an estimate of that individual's percentage energy from fat: The frequency reported categorically on the questionnaire was converted to the number of times fat was consumed per day as shown below. In general, the midpoint of the frequency range was used. Never 0.0 Less than once a month 0.018 1-3 times per month 0.066 1-2 times per week 0.214 3-4 times per week 0.499 5-6 times per week 0.784
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Daily Fruit and Vegetable Intake
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
NCI brief Fruit and Vegetable intake survey was used to measure dietary intake. Participants reported the frequency of each specific food eaten over the past 12 months. Values are:1 = never, 2 = less than once per month,3 = 1-3 times per week, 4 = 3-4 times per week,5 = 5-6 times per week, 6 = 1 time per day, 7 = 2 or more times per day. Higher scores indicate more frequent fruit and vegetable intake.There is no minimum or maximum available for this measure. The frequency reported categorically on the questionnaire was converted to the number of times fruits/vegetables were consumed per day as shown below. In general, the midpoint of the frequency range was used. Frequency ResponseTimes Per Day Never 0.0 Less than once a month 0.018 1-3 times per month 0.066 1-2 times per week 0.214 3-4 times per week 0.499 5-6 times per week 0.784
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Frequency of Added Sugar Intake
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
NCI brief Added Sugar intake survey was used to measure dietary intake. Participants reported the frequency of each specific food eaten over the past 12 months. Values are:1 = never, 2 = less than once per month,3 = 1-3 times per week, 4 = 3-4 times per week,5 = 5-6 times per week, 6 = 1 time per day, 7 = 2 or more times per day. Higher scores indicate more frequent fat intake.There is no minimum or maximum available for this measure. The frequency reported categorically on the questionnaire was converted to the number of times consumed per day as shown below. In general, the midpoint of the frequency range was used. Frequency ResponseTimes Per Day Never 0.0 Less than once a month 0.018 1-3 times per month 0.066 1-2 times per week 0.214 3-4 times per week 0.499 5-6 times per week 0.784
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Daily Physical Activity (Metabolic Equivalent Task MET)
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
The International Physical Activity Questionnaire Short Form (7 items) was be used to measure physical activity. Participants are asked to report frequency (days/week) and duration (hours/ day or minutes/day) of vigorous and moderate physical activities performed in the past 7 days. Participants were asked about 3 specific types of activity: walking, moderate-intensity activity, and vigorous-intensity activity. Participants also reported frequency (days per week) and duration (time per day) for each specific type of activity. To create metabolic equivalent of task (MET, energy expenditure) measures, we multiplied frequency by duration (in hours). We then used the summation times 3.3 MET (walking), 4.0 (moderate physical activity), and 8.0 (vigorous physical activity) to generate physical activity scores in MET units. Higher scores indicated more energy expenditure. |
baseline (T1) and 3 weeks follow up (T2)
|
|
Change in Autonomous Motivation for Stress Management
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
Autonomous motivation.
To measure autonomous motivation, we used the Treatment Self-Regulation Questionnaire (6 items for stress management).
Participants rated how true each statement was for them related to stress management using a 7-point scale: 1 (not at all true) to 7 (very true).
We summed responses to the 6 items to create a score for stress management.
Scores can range from 6 - 42.
Higher scores indicated higher autonomous motivation.
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Change in Autonomous Motivation for Healthy Eating
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
Autonomous motivation.
To measure autonomous motivation, we used the Treatment Self-Regulation Questionnaire (6 items for healthy eating).
Participants rated how true each statement was for them related to healthier eating using a 7-point scale: 1 (not at all true) to 7 (very true).
We summed responses to the 6 items to create a score for healthy eating.
Scores can range from 6 - 42 Higher scores indicated higher autonomous motivation.
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Change in Autonomous Motivation for Physical Activity
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
Autonomous motivation.
To measure autonomous motivation, we used the Treatment Self-Regulation Questionnaire (6 items for physical activity).
Participants rated how true each statement was for them related to physical activity using a 7-point scale: 1 (not at all true) to 7 (very true).
We summed responses to the 6 items to create a score for physical activity.
Scores can range from 6 -42.
Higher scores indicated higher autonomous motivation.
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Change in General Self-efficacy
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
Self-efficacy.
We used surveys to measure self-efficacy.
We also used the general self-efficacy scale (10 items) to measure self-efficacy.
Participants rated the truthfulness of each statement using a 4-point scale: 1 (not at all true) to 4 (exactly true).
We summed responses to the 10 items to create a score for general self-efficacy.
Scores can range from 10 - 40.
Higher scores meant higher self-efficacy.
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Change in Healthy Eating Self-efficacy
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
Self-efficacy. We used surveys to measure self-efficacy for healthy eating (8 items). Participants rated levels of confidence using a 4-point scale: 1 (not at all confident) to 4 (very confident). We summed responses to the 8 items to create a score for self-efficacy for healthy eating. THigher scores meant higher self-efficacy. Participants rated the truthfulness of each statement using a 4-point scale: 1 (not at all true) to 4 (exactly true). We summed responses to the 10 items to create a score for general self-efficacy. Scores can range from 8 - 32. Higher scores meant higher self-efficacy. |
baseline (T1) and 3 weeks follow up (T2)
|
|
Change in Physical Activity Self-efficacy
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
Self-efficacy.
We used surveys to measure physical activity (10 items).
Participants rated levels of confidence using a 4-point scale: 1 (not at all confident) to 4 (very confident).
We summed responses to the 10 items to create a score for self-efficacy for physical activity.
Higher scores meant higher self-efficacy.
Participants rated the truthfulness of each statement using a 4-point scale: 1 (not at all true) to 4 (exactly true).
We summed responses to the 10 items to create a score for general self-efficacy.
Scores can range from 10 - 40.
Higher scores meant higher self-efficacy.
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Change in Emotion Regulation
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
Emotional control.
To measure emotional control, we used the Emotion Regulation Questionnaire to assess the emotional regulatory process using reappraisal (6 items) and suppression (4 items).
Participants rated the degree of agreement using a 7-point scale: 1 (strongly disagree) to 7 (strongly agree).
The suppression items were reverse coded prior to score computation.
We summed responses to the 10 items to create a score for emotional control.
Scores could range between 10 - 70.
Higher scores meant better emotional control.
|
baseline (T1) and 3 weeks follow up (T2)
|
|
Change in Perceived Stress
Time Frame: baseline (T1) and 3 weeks follow up (T2)
|
We used the Perceived Stress Scale (10 items) to measure stress.
Participants rated the frequency of stressful life situations in the past month using a 4-point scale: 1 (never) to 4 (often).
We summed responses to the 10 items to create a score for stress.
Scores can range from 10-40.
Higher scores meant perceived higher levels of stress.
|
baseline (T1) and 3 weeks follow up (T2)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mei-Wei Chang, PhD, Ohio State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020B0322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Goal-oriented episodic future thinking
-
Ohio State UniversityCompletedObesity | Weight Gain, MaternalUnited States
-
University of VermontWithdrawnTobacco Smoking
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI); Roswell Park Comprehensive Cancer CenterNot yet recruitingCigarette Smoking BehaviorUnited States
-
Henry Ford Health SystemMichigan State University; University of Kansas; University of Maryland, College...Recruiting
-
Henry Ford Health SystemMichigan State University; University of Kansas; University of Maryland, College...CompletedBehavioral HealthUnited States
-
Virginia Polytechnic Institute and State UniversityNational Institute of Nursing Research (NINR); Carilion Clinic; University at...CompletedType 2 DiabetesUnited States
-
Henry Ford Health SystemUniversity of Kansas; University of Maryland, College ParkCompletedBehavioral HealthUnited States
-
Virginia Polytechnic Institute and State UniversityCarilion ClinicCompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Henry Ford Health SystemUniversity of Kansas; University of Maryland, College ParkActive, not recruiting
-
State University of New York at BuffaloCompletedMedication AdherenceUnited States